Item Type | Name |
Concept
|
Acute Disease
|
Concept
|
Actins
|
Concept
|
Adenocarcinoma
|
Concept
|
Atractyloside
|
Concept
|
Adaptation, Physiological
|
Concept
|
Biphenyl Compounds
|
Concept
|
Bone Marrow Cells
|
Concept
|
Aging
|
Concept
|
Antineoplastic Agents
|
Concept
|
Carcinoma, Squamous Cell
|
Concept
|
Aminopyridines
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
Concept
|
Analysis of Variance
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Histocompatibility Antigens Class II
|
Concept
|
Base Sequence
|
Concept
|
DNA Damage
|
Concept
|
Azacitidine
|
Concept
|
Carcinoma, Renal Cell
|
Concept
|
Biopsy
|
Concept
|
Carbonic Anhydrases
|
Concept
|
Cell Division
|
Concept
|
Cell Separation
|
Concept
|
Chromosomes, Human, Pair 15
|
Concept
|
Colonic Neoplasms
|
Concept
|
Chromosome Mapping
|
Concept
|
Genetic Vectors
|
Concept
|
Dacarbazine
|
Concept
|
Complement C3
|
Concept
|
Imidazoles
|
Concept
|
Cysteine Endopeptidases
|
Concept
|
Cytochrome c Group
|
Concept
|
Cytological Techniques
|
Concept
|
Dendritic Cells
|
Concept
|
Cytotoxicity, Immunologic
|
Concept
|
Chemotaxis, Leukocyte
|
Concept
|
Kidney Neoplasms
|
Concept
|
Exons
|
Concept
|
Cost-Benefit Analysis
|
Concept
|
Diagnostic Imaging
|
Concept
|
Cytomegalovirus
|
Concept
|
Drug Evaluation, Preclinical
|
Concept
|
Fibrinogen
|
Concept
|
Enzyme Activation
|
Concept
|
Microtubule-Associated Proteins
|
Concept
|
Gene Expression Regulation
|
Concept
|
Glioma
|
Concept
|
Nucleic Acid Hybridization
|
Concept
|
Genetic Engineering
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
Concept
|
Hematopoietic Stem Cells
|
Concept
|
Drug Combinations
|
Concept
|
Liposomes
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Hydroxamic Acids
|
Concept
|
Flow Cytometry
|
Concept
|
Gene Amplification
|
Concept
|
Granulocytes
|
Concept
|
Leukocytes, Mononuclear
|
Concept
|
Macrophages
|
Concept
|
Membrane Glycoproteins
|
Concept
|
Lymphocyte Culture Test, Mixed
|
Concept
|
Hydrolysis
|
Concept
|
Mice, Transgenic
|
Concept
|
Models, Genetic
|
Concept
|
Neutropenia
|
Concept
|
Markov Chains
|
Concept
|
Extracellular Matrix
|
Concept
|
Immunohistochemistry
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Mice, Nude
|
Concept
|
Mutation
|
Concept
|
HeLa Cells
|
Concept
|
Neutrophils
|
Concept
|
Phosphatidylinositols
|
Concept
|
Ovarian Neoplasms
|
Concept
|
Lipopolysaccharides
|
Concept
|
Lung Neoplasms
|
Concept
|
Major Histocompatibility Complex
|
Concept
|
NAD
|
Concept
|
Porphyrins
|
Concept
|
Prostatic Neoplasms
|
Concept
|
Piperazines
|
Concept
|
Frozen Sections
|
Concept
|
Histocompatibility Antigens
|
Concept
|
Repressor Proteins
|
Concept
|
Genes, ras
|
Concept
|
HLA-A2 Antigen
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Humans
|
Concept
|
Listeria monocytogenes
|
Concept
|
Cluster Analysis
|
Concept
|
Tomography, X-Ray Computed
|
Concept
|
Transcription, Genetic
|
Concept
|
Protein Biosynthesis
|
Concept
|
Interferon Type I
|
Concept
|
Intracellular Membranes
|
Concept
|
Gram-Positive Bacterial Infections
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Testis
|
Concept
|
Genetic Variation
|
Concept
|
Protein Engineering
|
Concept
|
HLA-A Antigens
|
Concept
|
Vaccination
|
Concept
|
CD28 Antigens
|
Concept
|
Histocompatibility Antigens Class I
|
Concept
|
Leukemia, Myeloid
|
Concept
|
Transduction, Genetic
|
Concept
|
Herpesvirus 1, Human
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Th1 Cells
|
Concept
|
Gene Library
|
Concept
|
Cell Culture Techniques
|
Concept
|
Drug Resistance, Neoplasm
|
Concept
|
Antibodies, Blocking
|
Concept
|
Intramolecular Oxidoreductases
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Caspases
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Mitogen-Activated Protein Kinases
|
Concept
|
S Phase
|
Concept
|
Transforming Growth Factor beta
|
Concept
|
NF-kappa B
|
Concept
|
Central Nervous System Neoplasms
|
Concept
|
Cell Adhesion Molecules
|
Concept
|
Up-Regulation
|
Concept
|
G1 Phase
|
Concept
|
PC12 Cells
|
Concept
|
Muromonab-CD3
|
Concept
|
Antigens, CD
|
Concept
|
3T3 Cells
|
Concept
|
Mitochondria
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
Interleukin-4
|
Concept
|
Receptor, Macrophage Colony-Stimulating Factor
|
Concept
|
Immunotherapy, Adoptive
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
Concept
|
Gene Expression
|
Concept
|
Stem Cell Transplantation
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Sequence Analysis, DNA
|
Concept
|
Methylation
|
Concept
|
Genes, Reporter
|
Concept
|
Mitochondria, Liver
|
Concept
|
Treatment Outcome
|
Concept
|
Gene Transfer Techniques
|
Concept
|
MAP Kinase Kinase 1
|
Concept
|
B7-1 Antigen
|
Concept
|
Mice, Knockout
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
DNA, Complementary
|
Concept
|
Cell Proliferation
|
Concept
|
Antigens, CD34
|
Concept
|
Thapsigargin
|
Concept
|
ras Proteins
|
Concept
|
Interleukin-12
|
Concept
|
Apoptosis Regulatory Proteins
|
Concept
|
Th2 Cells
|
Concept
|
Antineoplastic Agents, Alkylating
|
Concept
|
Transgenes
|
Concept
|
Staurosporine
|
Concept
|
Cancer Vaccines
|
Concept
|
Caspase 3
|
Concept
|
Fas Ligand Protein
|
Concept
|
Tumor Necrosis Factor Receptor Superfamily, Member 9
|
Concept
|
MAP Kinase Kinase Kinases
|
Concept
|
Genes, T-Cell Receptor
|
Concept
|
eIF-2 Kinase
|
Concept
|
Mutation, Missense
|
Concept
|
Lymphocyte Count
|
Concept
|
Lipopolysaccharide Receptors
|
Concept
|
Jurkat Cells
|
Concept
|
In Situ Hybridization, Fluorescence
|
Concept
|
Lab-On-A-Chip Devices
|
Concept
|
Myofibroblasts
|
Concept
|
Single-Cell Analysis
|
Concept
|
Exome
|
Concept
|
Clonal Evolution
|
Concept
|
Positron-Emission Tomography
|
Concept
|
Proteomics
|
Concept
|
bcl-2-Associated X Protein
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
Concept
|
Amino Acid Substitution
|
Concept
|
Proto-Oncogene Proteins B-raf
|
Concept
|
Indoleamine-Pyrrole 2,3,-Dioxygenase
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
Concept
|
Adoptive Transfer
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
Concept
|
CD40 Ligand
|
Concept
|
Gene Expression Profiling
|
Concept
|
Antineoplastic Protocols
|
Concept
|
bcl-X Protein
|
Concept
|
Photochemotherapy
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Mice
|
Concept
|
Caspase 8
|
Concept
|
Pyrimidinones
|
Concept
|
Pyrroles
|
Concept
|
Chemokine CCL1
|
Concept
|
Saccharomyces cerevisiae
|
Concept
|
Unfolded Protein Response
|
Concept
|
HEK293 Cells
|
Concept
|
Molecular Targeted Therapy
|
Concept
|
Rats
|
Concept
|
Natural Killer T-Cells
|
Concept
|
Cell Engineering
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Concept
|
CTLA-4 Antigen
|
Concept
|
Spleen
|
Concept
|
Vancomycin
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
Blotting, Western
|
Concept
|
Monitoring, Immunologic
|
Concept
|
Down-Regulation
|
Concept
|
PTEN Phosphohydrolase
|
Concept
|
Survival Analysis
|
Concept
|
Hepacivirus
|
Concept
|
DNA Copy Number Variations
|
Concept
|
Molecular Imaging
|
Concept
|
Open Reading Frames
|
Concept
|
Transfection
|
Concept
|
Blotting, Northern
|
Concept
|
Electrophoresis, Gel, Two-Dimensional
|
Concept
|
Reproducibility of Results
|
Concept
|
Genetic Therapy
|
Concept
|
Genome, Human
|
Concept
|
Killer Cells, Lymphokine-Activated
|
Concept
|
Survival Rate
|
Concept
|
Polymerase Chain Reaction
|
Concept
|
Amyloid beta-Peptides
|
Concept
|
HL-60 Cells
|
Concept
|
Chemokine CCL2
|
Concept
|
DNA Methylation
|
Concept
|
Receptors, CCR2
|
Concept
|
Interleukin-17
|
Concept
|
Gene Silencing
|
Concept
|
Imaging, Three-Dimensional
|
Concept
|
Xenograft Model Antitumor Assays
|
Concept
|
Hematologic Neoplasms
|
Concept
|
Histone Deacetylase Inhibitors
|
Concept
|
Phosphatidylinositol 3-Kinases
|
Concept
|
K562 Cells
|
Concept
|
Genes, Transgenic, Suicide
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
Concept
|
T-Lymphocytes, Regulatory
|
Concept
|
gp100 Melanoma Antigen
|
Concept
|
B7-2 Antigen
|
Concept
|
TNF-Related Apoptosis-Inducing Ligand
|
Concept
|
Granzymes
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily A
|
Concept
|
Precision Medicine
|
Concept
|
Tumor Microenvironment
|
Concept
|
Lectins, C-Type
|
Concept
|
Programmed Cell Death 1 Receptor
|
Concept
|
Cell Line, Tumor
|
Concept
|
T Cell Transcription Factor 1
|
Concept
|
MART-1 Antigen
|
Concept
|
Alzheimer Disease
|
Concept
|
Antibodies
|
Concept
|
Brain Neoplasms
|
Concept
|
Calcium
|
Concept
|
Cell Line
|
Concept
|
Cell Survival
|
Concept
|
Cells, Cultured
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Cloning, Molecular
|
Concept
|
Disease Models, Animal
|
Concept
|
DNA Restriction Enzymes
|
Concept
|
DNA, Single-Stranded
|
Concept
|
Drug Resistance, Microbial
|
Concept
|
Drug Screening Assays, Antitumor
|
Concept
|
Fever
|
Concept
|
Histidine
|
Concept
|
Immunoglobulins
|
Concept
|
Kinetics
|
Concept
|
Lymphocyte Activation
|
Concept
|
Lymphocytes
|
Concept
|
Membrane Potentials
|
Concept
|
Monocytes
|
Concept
|
Nitrophenols
|
Concept
|
Protoporphyrins
|
Concept
|
Pyridones
|
Concept
|
Recombinant Fusion Proteins
|
Concept
|
Retrospective Studies
|
Concept
|
T-Lymphocytes
|
Concept
|
Thymus Gland
|
Concept
|
Uveal Neoplasms
|
Concept
|
Gene Expression Regulation, Neoplastic
|
Concept
|
Immunophenotyping
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
Concept
|
Cytokines
|
Concept
|
Mice, SCID
|
Concept
|
Mice, Inbred NOD
|
Concept
|
Sequence Analysis, RNA
|
Concept
|
DNA Primers
|
Concept
|
Gelsolin
|
Concept
|
Coculture Techniques
|
Concept
|
Computational Biology
|
Concept
|
Complementarity Determining Regions
|
Concept
|
MicroRNAs
|
Concept
|
Intracellular Space
|
Concept
|
Epigenesis, Genetic
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
Caspase 9
|
Academic Article
|
A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.
|
Academic Article
|
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
|
Academic Article
|
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
|
Academic Article
|
Active Immunotherapy of Cancer.
|
Academic Article
|
CTLA4 blockade broadens the peripheral T-cell receptor repertoire.
|
Academic Article
|
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.
|
Academic Article
|
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function.
|
Academic Article
|
The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
|
Academic Article
|
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
|
Academic Article
|
A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells.
|
Academic Article
|
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
|
Academic Article
|
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
|
Academic Article
|
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
|
Academic Article
|
Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance.
|
Academic Article
|
A rare population of tumor antigen-specific CD4+CD8+ double-positive aß T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.
|
Academic Article
|
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.
|
Academic Article
|
HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.
|
Academic Article
|
Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies.
|
Academic Article
|
The impact of ex vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy.
|
Academic Article
|
Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma.
|
Academic Article
|
Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
|
Academic Article
|
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.
|
Academic Article
|
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.
|
Academic Article
|
Natural killer T cells in advanced melanoma patients treated with tremelimumab.
|
Academic Article
|
Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses.
|
Academic Article
|
Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models.
|
Academic Article
|
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans.
|
Academic Article
|
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines.
|
Academic Article
|
Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses.
|
Academic Article
|
Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.
|
Academic Article
|
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.
|
Academic Article
|
Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.
|
Academic Article
|
A cloning method for caspase substrates that uses the yeast two-hybrid system: cloning of the antiapoptotic gene gelsolin.
|
Academic Article
|
Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release.
|
Academic Article
|
Human antigen-specific regulatory T cells generated by T cell receptor gene transfer.
|
Academic Article
|
Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines.
|
Academic Article
|
Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression.
|
Academic Article
|
Measurement and Quantitative Characterization of Whole-Body Pharmacokinetics of Exogenously Administered T Cells in Mice.
|
Academic Article
|
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes.
|
Academic Article
|
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.
|
Academic Article
|
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies.
|
Academic Article
|
Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC.
|
Academic Article
|
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model.
|
Academic Article
|
The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
|
Academic Article
|
Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect.
|
Academic Article
|
Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery.
|
Academic Article
|
siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide.
|
Academic Article
|
Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway.
|
Academic Article
|
The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors.
|
Academic Article
|
Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
|
Academic Article
|
Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors.
|
Academic Article
|
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.
|
Academic Article
|
Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.
|
Academic Article
|
Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer.
|
Academic Article
|
T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFß) signaling mediate superior tumor regression in an animal model of adoptive cell therapy.
|
Academic Article
|
Immune rejection in a humanized model of murine prostate cancer.
|
Academic Article
|
Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.
|
Academic Article
|
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
|
Academic Article
|
Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.
|
Academic Article
|
Immunosensitization with a Bcl-2 small molecule inhibitor.
|
Academic Article
|
Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancer.
|
Academic Article
|
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction.
|
Academic Article
|
Inhibition of Alzheimer's amyloid-beta peptide-induced reduction of mitochondrial membrane potential and neurotoxicity by gelsolin.
|
Academic Article
|
Adoptive cell transfer of T-cell receptor-engineered lymphocytes: lessons from recent modeling.
|
Academic Article
|
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
|
Academic Article
|
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
|
Academic Article
|
Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific T cells.
|
Academic Article
|
Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokers.
|
Academic Article
|
Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro.
|
Academic Article
|
Engineered microenvironment for the study of myofibroblast mechanobiology.
|
Academic Article
|
CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer.
|
Academic Article
|
Engineering tumor stromal mechanics for improved T cell therapy.
|
Academic Article
|
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
|
Academic Article
|
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
|
Academic Article
|
Correction to: Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
|
Academic Article
|
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses.
|
Academic Article
|
pH Sensitive Erythrocyte-Derived Membrane for Acute Systemic Retention and Increased Infectivity of Coated Oncolytic Vaccinia Virus.
|
Concept
|
Erlotinib Hydrochloride
|
Concept
|
Carbonic Anhydrase IX
|